செங்கல்பட்டு #HLLbiotech நிறுவனத்தின் #Vaccine ஆய்வகத்தை நேரில் ஆய்வு செய்து உடனடியாகத் தடுப்பூசி உற்பத்தியைத் தொடங்கிடும் முயற்சிகளை மேற்கொள்ளக்...
Chief Minister M.K. Stalin inspected the Chengalpattu HLL Biotech complex, pledging full state cooperation and demanding Union funds to start vaccine manufacturing.
M.K.Stalin@mkstalinOriginal post
செங்கல்பட்டு #HLLbiotech நிறுவனத்தின் #Vaccine ஆய்வகத்தை நேரில் ஆய்வு செய்து உடனடியாகத் தடுப்பூசி உற்பத்தியைத் தொடங்கிடும் முயற்சிகளை மேற்கொள்ளக் கேட்டுக் கொண்டேன்.
தேவையான அனைத்து உதவிகளையும் தமிழக அரசு செய்யும்.
மத்திய அரசும் நிதி ஒதுக்கீடு செய்து உதவிட வேண்டும்.
@PMOIndia https://t.co/1RHZoHHf1d
Demonstrating hands-on determination to resolve nationwide immunization bottlenecks, Chief Minister M.K. Stalin conducted an extensive personal inspection of the Integrated Vaccine Complex operated by Central Public Sector Undertaking HLL Biotech in Chengalpattu. Stalin walked through the state-of-the-art laboratory facilities, cold storage chains, and modern formulation suites, holding direct discussions with resident scientists, bio-pharmaceutical engineers, and senior health administrators on operationalizing stalled vaccine production lines immediately.
The Chief Minister pledged that the Tamil Nadu government is fully prepared to provide comprehensive logistical support, emergency power connections, water infrastructure, and administrative clearances required to commence commercial operations. Stalin called upon Prime Minister Narendra Modi and the Union Ministry of Health to allocate requisite operational funding or facilitate joint ventures without delay. He stressed that leaving world-class vaccine manufacturing infrastructure idle during a devastating viral pandemic is an unpardonable waste of national resources when millions of citizens urgently await inoculation.
Stalin bold site visit demonstrated practical, proactive leadership focused on scientific problem-solving. By personally assessing the Chengalpattu facility and pressing for federal activation, his administration highlighted a viable path toward national vaccine self-reliance and expanded immunization access.